10mg 20mg 30mg Peptides Tirzepatide for Blood Sugar Control Studies cas 2023788-19-2

Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that is being developed for the treatment of type 2 diabetes. Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide.

Tirzepatide, also known as LY 3298176, is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies reported that tirzepatide mimics the actions of natural GIP at the GIP receptor. Tirzepatide was approved for improving blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.

Applications:
Lowers blood sugar: Tirzepatide can promote the secretion and inhibit the secretion of glucagon, thereby effectively lowering blood sugar levels. In clinical trials, Tirzepatide showed more significant hypoglycemic effects than GLP-1 receptor agonists currently on the market.
Weight Loss: Tirzepatide has also shown significant weight loss effects. Because it suppresses appetite and increases satiety, it can help patients control their diet and reduce calorie intake, thereby achieving weight loss.
Reduces cardiovascular risk: Tirzepatide has also been shown in clinical trials to reduce the risk of cardiovascular events. This may be due to the combined effect of its ability to lower blood sugar, lower blood pressure, reduce weight, and other factors.

--Helps slow food leaving your stomach
--Helps prevent your liver from making too much sugar
--Helps the pancreas produce more insul when your blood sugar levels are high
--Can help control blood glucose
--Can reduce hyperglycemia, especially after meals
--Can reduce fasting insul and fasting glucose
--Can reduce hemoglobin A1c
--Can decrease appetite and caloric intake, while inhibiting weight gain
--Has been shown to lower triglyceride levels and oxidative stress from high LDL
--Has been shown to help induce weight loss in obese patients with higher dosing
--Helps decrease leptin and increase leptin sensitivity
--Can increase the conversion of white fat to brown fat

Product Photo:

Haikou Mingheng Biotechnology Co., Ltd, is a pioneering force in the biotechnology sector. At the core of our operations is the unwavering commitment to our guiding principles: "Quality First, Service Supreme."

Business Philosophy:
"Quality First, Service Supreme" encapsulates our business philosophy. We firmly believe that prioritizing quality in all aspects of our operations and providing exceptional service form the foundation for enduring success.

Key Products:
Our primary focus encompasses a range of products, including weight loss peptides, medicinal peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Semaglutide, Tirzepatide, Retatrutide, and others.

Mission:
Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

Customized Peptides:
In addition to our standard product line, we specialize in crafting customized peptides tailored to meet the unique needs of our diverse clientele.

Future Vision:
As we move forward, Haikou Mingheng Biotechnology Co., Ltd. is poised for continued growth and innovation. We are committed to expanding our product portfolio, staying at the forefront of technological advancements, and exceeding the expectations of our valued clients.

At Haikou Mingheng Biotechnology Co., Ltd, we are not just shaping the future of biotechnology; we are pioneering a path towards a healthier and more sustainable world.